Moderna
Stay current with all the latest and breaking news about Moderna, compare headlines and perspectives between news sources on stories happening today. In total, 70 stories have been published about Moderna which Ground News has aggregated in the past 3 months.Stay current with all the latest and breaking news about Moderna, compare headlines and perspectives between news sources on stories happening today. In total, 70 stories have been published about Moderna which Ground News has aggregated in the past 3 months.
Covered Most By
Local News Publishers
No sources with tracked biases.
See less detail
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Moderna News
Latest News Stories
Bernie Sanders · WashingtonSen. Bernie Sanders (I-Vt.) plans to question the CEO of Moderna during a hearing next month about the company’s plans to quadruple the price of its COVID-19 vaccine.
Sanders to grill Moderna CEO over proposed COVID vaccine price hike
50% Left coverage: 12 sources
Business · CambridgeModerna Inc (MRNA.O) said on Tuesday that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.
Moderna reports RSV vaccine for older adults is 84% effective
58% Center coverage: 24 sources
Moderna · New YorkModerna has developed a new mRNA shot meant to treat patients who suffered heart failure, according to CEO Stéphane Bancel.
Moderna CEO Stéphane Bancel Announces New mRNA Shot to Treat Heart Failure Patients
100% Right coverage: 6 sources
EuropeModerna and Merck's personalized mRNA cancer vaccine mRNA-4157/V940, in combination with Keytruda, for the adjuvant treatment of patients with high-risk melanoma after complete resection. FDA's decision was backed by data from a phase 2b trial, dubbed KEYNOTE-942/mRNA- 4157-P201.
Moderna, Merck's mRNA cancer vaccine, Keytruda combo gets FDA breakthrough therapy tag
67% Center coverage: 3 sources
ModernaThe company was not authorized to use its vaccine in the country; if allowed, it will be the sixth in application
Anvisa receives emergency request for Moderna's Covid-19 vaccine, still unused in Brazil
ModernaCytomX to receive $35 million upfront payment with the potential for additional research, milestone, and royalty payments. Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing. CytomX's Probody technology enables proteins to be activated locally in diseased tissue.
CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Moderna · OxfordshireCovid-19 vaccine manufacturer Moderna has announced its new research and manufacturing base is to be built in Oxfordshire. The biotechnology company will create its Moderna Innovation and Technology Centre in Harwell. Move is set to create hundreds of jobs both in the construction as well as the operation of the manufacturing facility.
Oxfordshire named as home for new Moderna vaccine manufacturing hub
100% Right coverage: 1 sources
